Radical Nephrectomy for a Giant Chromophobe Renal Cell Carcinoma Diagnosed > 17 Years Previously: a Case Report and Literature Review

Overview

Journal Front Oncol

Specialty Oncology

Date 2024 Apr 18

PMID 38634044

Authors

Jianhua Lan

Dong Lan

Wenqiang Yuan

Qiao Ying

Jiahong He

Yonglin Gu

Affiliations

Soon will be listed here.

Abstract

Early diagnosis of renal cell carcinoma relies on imaging tests such as ultrasound, computed tomography, or magnetic resonance imaging. Since surgery is associated with a favorable prognosis, the standard treatment for clinically limited renal cell carcinoma remains surgical resection. Among asymptomatic patients with localized renal cell carcinoma, a small number refuse surgical treatment and survive. We report a case involving a 59-year-old female who underwent a difficult radical nephrectomy 17 years after being diagnosed with malignant tumors due to primary renal cell carcinoma.

References

Moslemi M, Hosseini S, Firoozabadi M . A Huge Renal Cell Carcinoma, Nine Years after Its Primary Diagnosis and Obligate Observation. Case Rep Oncol. 2010; 3(3):326-333. PMC: 2974969. DOI: 10.1159/000320941. View

Dudani S, de Velasco G, Wells J, Gan C, Donskov F, Porta C . Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival. JAMA Netw Open. 2021; 4(1):e2021869. PMC: 7821027. DOI: 10.1001/jamanetworkopen.2020.21869. View

Wu M, Liaw C, Chen Y, Tian Y, Hsueh S, Jenq C . A giant sarcomatoid renal cell carcinoma. Nephrol Dial Transplant. 2006; 22(3):952-3. DOI: 10.1093/ndt/gfl746. View

Zhang L, Li X, Zhou L . Natural history of small renal masses. Chin Med J (Engl). 2015; 128(9):1232-7. PMC: 4831552. DOI: 10.4103/0366-6999.156139. View

Taneja R, Singh D . Giant renal angiomyolipoma: unusual cause of huge abdominal mass. J Clin Imaging Sci. 2014; 3:56. PMC: 3883275. DOI: 10.4103/2156-7514.122326. View

Celebioglu E, Bilgic S, Merter A, Karaca M, Basarir K, Yildiz H . Scheduling surgery after transarterial embolization: does timing make any difference to intraoperative blood loss for renal cell carcinoma bone metastases?. Diagn Interv Radiol. 2021; 27(6):740-745. PMC: 8621631. DOI: 10.5152/dir.2021.21011. View

Giannarini G . Case Presentation: A 63-year-old Man with Bilateral Adrenal Mass and Large Renal Cell Carcinoma. Eur Urol Focus. 2017; 1(3):293-294. DOI: 10.1016/j.euf.2015.08.005. View

Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L . Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022; 39(3). View

Siegel R, Miller K, Wagle N, Jemal A . Cancer statistics, 2023. CA Cancer J Clin. 2023; 73(1):17-48. DOI: 10.3322/caac.21763. View

10.

Gagnier J, Kienle G, Altman D, Moher D, Sox H, Riley D . The CARE guidelines: consensus-based clinical case reporting guideline development. Headache. 2013; 53(10):1541-7. DOI: 10.1111/head.12246. View

11.

Takeda K, Murray G, Vohra N, Fallon J . A case of the world's largest renal cell carcinoma. IJU Case Rep. 2021; 4(1):49-52. PMC: 7784761. DOI: 10.1002/iju5.12236. View

12.

Suzuki K, Kubo T, Morita T . A giant chromophobe renal cell carcinoma exceeding 10 kg. Int J Urol. 2009; 16(12):976. DOI: 10.1111/j.1442-2042.2009.02402.x. View

13.

Souto Filho J, Silveira A, Lacerda A, Pires A, Sales L, Dias Y . Erythropoietin-producing clear cell renal cell carcinoma associated with secondary polycythemia. Hematol Transfus Cell Ther. 2020; 43(2):226-227. PMC: 8211621. DOI: 10.1016/j.htct.2020.04.007. View

14.

Oviedo R, Robertson J, Whithaus K . Surgical challenges in the treatment of a giant renal cell carcinoma with atypical presentation: A case report. Int J Surg Case Rep. 2016; 24:63-6. PMC: 4873688. DOI: 10.1016/j.ijscr.2016.05.010. View

15.

Ohashi R, Martignoni G, Hartmann A, Calio A, Segala D, Stohr C . Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme. Virchows Arch. 2019; 476(3):409-418. DOI: 10.1007/s00428-019-02710-w. View

16.

Carvalho L, Jorge S, Lopez-Fernandez H, Lodeiro C, Dhir R, Pinheiro L . Proteomic analysis of chromophobe renal cell carcinoma and benign renal oncocytoma biopsies reveals shared metabolic dysregulation. Clin Proteomics. 2023; 20(1):54. PMC: 10683195. DOI: 10.1186/s12014-023-09443-8. View

17.

Ameri C, Pita H, Vitagliano G, Blas L . Renal tumor growth rate in patients with previously normal CT scan: Analysis of the initial stage of growth. Turk J Urol. 2020; 47(1):9-13. PMC: 7815238. DOI: 10.5152/tud.2020.20201. View

18.

El-Shorbagy S, Alshenawy H . Diagnostic utility of vimentin, CD117, cytokeratin-7 and caveolin-1 in differentiation between clear cell renal cell carcinoma, chromophobe renal cell carcinoma and oncocytoma. J Microsc Ultrastruct. 2018; 5(2):90-96. PMC: 6025761. DOI: 10.1016/j.jmau.2016.07.005. View

19.

Finelli A, Cheung D, Al-Matar A, Evans A, Morash C, Pautler S . Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort. Eur Urol. 2020; 78(3):460-467. DOI: 10.1016/j.eururo.2020.06.053. View

20.

Yang S, Jian Y, Yang F, Liu R, Zhang W, Wang J . Radiomics analysis based on single phase and different phase combinations of radiomics features from tri-phasic CT to distinguish renal oncocytoma from chromophobe renal cell carcinoma. Abdom Radiol (NY). 2023; 49(1):182-191. DOI: 10.1007/s00261-023-04053-2. View